| Literature DB >> 27652326 |
Clément Chevalier1, Serge Roche1, Christine Bénistant2.
Abstract
ERBB2 (v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2) amplification is associated with invasive breast cancer. We discovered that TOM1L1 (target of myb1-like 1) and ERBB2 co-amplification defines a novel mechanism involved in breast cancer metastatic progression. Upregulation of the vesicular trafficking protein TOM1L1 enhances plasma membrane delivery of membrane-type 1 matrix metalloprotease (MT1-MMP) for efficient extracellular matrix degradation and tumor cell dissemination.Entities:
Keywords: Breast cancer; metastasis; tumor cell signaling; tyrosine kinase; vesicular trafficking
Year: 2016 PMID: 27652326 PMCID: PMC4972109 DOI: 10.1080/23723556.2016.1182241
Source DB: PubMed Journal: Mol Cell Oncol ISSN: 2372-3556